Site Map

Home

• Corporate Overview
• Management
• Contact Us
• Board of Directors
• Careers
• Evogene Ltd.
• Offices & Contacts

• Overview
• CGEN-15001
• CGEN-855
• CGEN-856 & CGEN-857
• CGEN-25007
• CGEN-25008
• CGEN-25009
• CGEN-25017
• CGEN-241
• CGEN-54
• CGEN-34
• Therapeutic Collaborations

• Overview
• mAb Targets Discovery Platform
• CGEN-671
• CGEN-928
• CGEN-144
• CGEN-438
• CGEN-6

• Overview
• GPCR Ligands
• Disease Associated Conformation peptide blockers
• Protein-Protein Interaction Blockers
• Intracellular Drug Delivery
• Genomic Markers
• Drug-induced Toxicity Biomarkers
• Nucleic Acid Diagnostics
• Immunoassay Diagnostics
• New Indications for Existing Drugs
• Biosystems Modeling
• Scientific Publications
• Research Collaborations

• Overview
• Therapeutic Collaborations
• mAb Targets Collaborations
• Research & Discovery Collaborations
• mAb Targets Collaborations

• Investors
• Overview
• Financial Reports
• Press Releases
• Events
• Press Clippings
• Corporate Governance
• Request Information
• Stock Quote